What this means: Semaglutide = strong appetite + fullness effect via GLP-1 Tirzepatide + added GIP receptor action + GLP-1, which may translate into greater weight reduction These medications are used for adults with obesity receiving semaglutide or obesity receiving tirzepatide, and are effective for weight management in these populations
Small-scale studies in patients on hemodialysis show promising results with decreased risk of hypoglycemia, reduction in insulin dose requirement, and improved glycemic control with use of GLP1-RA 15,16
These injections work with your bodys existing metabolic pathways, not against them
However, most of these studies lacked rigorous exclusion criteria in the selection of subjects to avoid the influence of confounders
This is the formulation gotcha most pages skip entirely
Some of these compound pharmacies, they know the rules, said Lee